Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rigaku Launches New X-Ray Microscope

Published: Tuesday, February 18, 2014
Last Updated: Tuesday, February 18, 2014
Bookmark and Share
Rigaku’s nano3DX X-ray microscope debuted at ACMM23 & ICONN2014.

Rigaku has announced the release of the nano3DX X-ray microscope, which debuted at ACMM23 & ICONN2014 (the 23rd Australian Conference on Microscopy and Microanalysis and the International Conference on Nanoscience and Nanotechnology).

The nano3DX is a new product for Rigaku, which has a long history and significant expertise in analytical X-ray related technologies such as X-ray diffraction (XRD), X-ray fluorescence (XRF) and non-destructive testing (NDT). It is a true X-ray microscope (XRM) with the ability to measure relatively large samples at high resolution.

As an X-ray microscope, the nano3DX images the entire sample from multiple angles. In doing so, it can reconstruct a 3D image at 0.27 µm resolution. The computer model allows the user to view sections at any point on any plane, providing valuable insights into the structure of the sample.

The secret behind the Rigaku nano3DX is the high-power rotating anode and high-resolution optics coupled with sub-micron CCD technology. This combination is capable of fast data collection and has the ability to switch anode materials rapidly to optimize data acquisition. Furthermore, the magnification occurs in the detector using true microscope elements.

The geometry of the system allows the sample to be located very close to the high-resolution detector, which provides near-parallel beam optics. This design results in improved instrument stability, which prevents smearing, allows for faster data collection times and ultimately yields the highest resolution X-ray microscope in its class.

One of the other advantages of the nano3DX over other instruments is its ultra-wide field of view. The nano3DX is able to measure volumes up to 25 times larger in a single scan compared to other systems at similar resolutions in comparable time frames.

Primary anode materials used in the nano3DX are copper, chromium and molybdenum. The choice of these anode materials gives the system the flexibility to optimize the X-rays for penetration and contrast based on the atomic weights of materials present in the sample.

X-ray microscopy is suited to all kinds of materials, from low density materials such as biological samples to high density materials such as ceramics and steels. XRM is even suitable for materials with low absorption contrast, like CFRPs and pharmaceuticals.

Applications for the nano3DX are many and varied, from materials science to electronics and semiconductors to mining and minerals exploration to life sciences and pharmaceuticals.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rigaku Raman Technologies Announces Rebrand to Rigaku Analytical Devices
Rigaku Analytical Devices sets benchmark in spectroscopy industry with portfolio of powerful customizable handheld and portable spectroscopic analyzers.
Friday, June 05, 2015
Rebrand for Rigaku Raman Technologies
Rigaku Raman Technologies has announced it will formally operate as Rigaku Analytical Devices.
Monday, June 01, 2015
Rigaku Announce New President & COO
Company appoints Mr. Yoichi Yokomizo as Chief Operating Officer of RAH.
Tuesday, April 07, 2015
Rigaku to Acquire Agilent’s X-Ray Diffraction Business
Company plans to combine XRD with its existing crystallography business to form a new business unit.
Wednesday, April 01, 2015
European Crystallography Meeting delegates Raise Money for Charity
Cycling enthusiasts at the 28th European Crystallography Meeting (ECM) have used the occasion to raise money for Cancer Research.
Wednesday, October 02, 2013
Rigaku and Emerald Bio Announce Strategic Alliance
Partnership to broaden customer solutions in protein crystallography.
Thursday, August 01, 2013
Analysis of Sulfur and Chlorine in Oil by Energy Dispersive X-ray Fluorescence
Monitoring the sulfur and chlorine content is critical in the production of various oils and oil products.
Wednesday, May 15, 2013
Texas State University Acquires Rigaku SCXmini Chemical Crystallography Instrument
The University has purchased the benchtop small molecule XRD crystallography instrument for Cyber-enabled for cyber-enabled teaching and research.
Thursday, January 08, 2009
Monash University Purchases Rigaku CrystalMation system for The Protein Crystallography Unit
The system is chosen in support of macromolecular crystallographic studies carried out by researchers at Monash University and their collaborative partners.
Friday, September 26, 2008
Rigaku Wins "Most Innovative New Technology" Award for CrystalMation™ and Desktop Minstrel™ UV Products
Company receives award for the Rigaku Desktop Minstrel UV system and Rigaku CrystalMation system at the ELRIG Protein Crystallography Conference.
Wednesday, April 23, 2008
Rigaku Sponsors Carl Brändén Award
The 2007 Carl Brändén Award was presented to Prof. Lubert Stryer for his exceptional contributions to education in biochemistry and molecular biology.
Monday, June 04, 2007
Rigaku Leads in Protein Structure Productivity Based on Analysis of Protein Data Bank Submissions
Data show that structures solved with Rigaku home laboratory X-ray generators comprised 17% of all submitted structures for 2005.
Wednesday, March 07, 2007
Rigaku Launches new Corporate Website
The website integrates all Rigaku products and business units with a common look and feel for an enhanced Internet browsing experience.
Wednesday, November 01, 2006
Rigaku Announces Reorganization
Rigaku Americas Corporation became the operating entity in charge of North America.
Tuesday, October 18, 2005
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!